MicroRNA-based Targeted Therapeutics in Pancreatic Cancer

Nilgun Gurbuz1, Bulent Ozpolat2

  • 1Department of Medical Biology, School of Medicine, Suleyman Demirel University, Isparta, Turkey.

Anticancer Research
|February 4, 2019
PubMed

Insights

MicroRNAs (miRNAs) are revolutionizing molecular oncology by regulating cancer pathways. miRNA-based therapies offer promising, targeted cancer treatments with potentially fewer side effects than traditional methods.

Area of Science:

  • Molecular Oncology
  • Genetics
  • Biotechnology

Background:

  • MicroRNAs (miRNAs) have emerged as critical regulators in both normal physiology and human tumor pathogenesis over the past decade.
  • These small non-coding RNAs significantly impact tumorigenesis, cell progression, invasion, angiogenesis, and metastasis by modulating oncogenic pathways.
  • Their dysregulation is implicated in numerous cancer types, highlighting their role in disease development.

Purpose of the Study:

  • To explore the revolutionary impact of microRNAs in molecular oncology.
  • To discuss the potential of miRNA-based therapeutics in cancer treatment.
  • To highlight the promise of targeted miRNA therapies over conventional treatments.

Main Methods:

  • Review of recent discoveries and research in microRNA biology and cancer.
  • Analysis of the role of miRNAs in oncogenic pathways and cancer progression.
  • Evaluation of the therapeutic potential of inhibiting oncogenic miRNAs (oncomiRs) or restoring tumor suppressor miRNAs.

Main Results:

  • MicroRNAs are key regulators of critical molecular pathways in cancer.
  • Oncogenic miRNAs (oncomiRs) and tumor suppressor miRNAs are significant players in tumorigenesis.
  • miRNA-based therapeutics demonstrate potential for targeted cancer treatment.

Conclusions:

  • MicroRNAs represent a revolutionary advancement in molecular oncology.
  • miRNA-based therapeutics hold significant promise for developing more effective and potentially safer cancer treatments.
  • Targeted miRNA therapies could transform cancer care, offering improved efficacy and reduced adverse effects compared to chemoradiation.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
Therapeutic Communication01:30

Therapeutic Communication

Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.0K